Albumin-bound paclitaxel is a microtubule inhibitor best efficient when used to treat NSCLC, either as a single therapy or as part of some combination [29] Albumin-bound paclitaxel, also known as nab-Paclitaxel, is a solvent-free formulation developed over a decade ago that delivers a higher dose of Paclitaxel to solid tumors while reducing the incidence of toxicities [30]. This evidence concerns the gene ALB and non-small cell lung carcinoma.